Entero Therapeutics, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
Renaissance Technologies LLC and its parent company have reported a beneficial ownership of 0.92% in GridAI Technologies Corp. common stock.
Strategic EP, LLC and Alexander Chase Deitch have jointly reported a 5.0% beneficial ownership stake in GridAI Technologies Corp., totaling 209,541 shares of common stock.
Renaissance Technologies LLC and its parent company have reported a passive 5.44% ownership stake in Entero Therapeutics, Inc.